Cargando…

A Bibliometric Analysis of the Oligometastatic State over the Last Two Decades: A Shifting Paradigm for Oncology? An AIRO Oligometastatic Study Group

SIMPLE SUMMARY: The concept of “oligometastatic state” has brought about a shift in our understanding of cancer’s metastasis and progression, and its management remains an active field of research, with ongoing efforts to develop new treatment options. The aim of the present study is to report a bib...

Descripción completa

Detalles Bibliográficos
Autores principales: Marvaso, Giulia, Mastroleo, Federico, Corrao, Giulia, Zaffaroni, Mattia, Vincini, Maria Giulia, Borghetti, Paolo, Cuccia, Francesco, Federico, Manuela, Montesi, Giampaolo, Pontoriero, Antonio, Franceschini, Davide, Franzese, Ciro, Scorsetti, Marta, Jereczek-Fossa, Barbara Alicja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417037/
https://www.ncbi.nlm.nih.gov/pubmed/37568718
http://dx.doi.org/10.3390/cancers15153902
_version_ 1785087924496236544
author Marvaso, Giulia
Mastroleo, Federico
Corrao, Giulia
Zaffaroni, Mattia
Vincini, Maria Giulia
Borghetti, Paolo
Cuccia, Francesco
Federico, Manuela
Montesi, Giampaolo
Pontoriero, Antonio
Franceschini, Davide
Franzese, Ciro
Scorsetti, Marta
Jereczek-Fossa, Barbara Alicja
author_facet Marvaso, Giulia
Mastroleo, Federico
Corrao, Giulia
Zaffaroni, Mattia
Vincini, Maria Giulia
Borghetti, Paolo
Cuccia, Francesco
Federico, Manuela
Montesi, Giampaolo
Pontoriero, Antonio
Franceschini, Davide
Franzese, Ciro
Scorsetti, Marta
Jereczek-Fossa, Barbara Alicja
author_sort Marvaso, Giulia
collection PubMed
description SIMPLE SUMMARY: The concept of “oligometastatic state” has brought about a shift in our understanding of cancer’s metastasis and progression, and its management remains an active field of research, with ongoing efforts to develop new treatment options. The aim of the present study is to report a bibliometric analysis of the oligometastatic disease/state to provide an overview of the topic. A total of 3304 documents were collected from 1995 to 2022. Among all keywords used by authors, the top three were oligometastases (19%), SBRT (18%), and radiation therapy (8%). In particular, a link can be observed between radiotherapy and topics of side-fields like immunotherapy and targeted therapies, representing an opportunity for further combinatorial studies in this setting. This bibliometric analysis represents a detailed summary of the most influential studies dealing with the oligometastatic state and sheds light on the area for the attention of researchers worldwide. ABSTRACT: The term “oligometastasis” represents a relatively novel idea, which denotes a condition characterized by cancer dissemination with a limited number of lesions (usually fewer than five). The aim of the present study is to report a bibliometric analysis of the oligometastatic disease/state, incorporating all relevant studies on the topic for more than 20 years. The research strategy included at least one the terms “Oligmetastases”, “Oligometastasis”, “Oligometastatic”, “Oligoprogression, “Oligoprogressive”, “Oligorecurrent”, or “Oligorecurrency” in the title, abstract, and/or keywords. All English-language documents from 1 January 1995 (the year of the earliest available document in Scopus) to 31 December 2022 were considered for the analysis. R code (R version 4.2.0) with R Studio (version 2022.12.0-353) and the Bibliometrix package (version 4.0.1) were used for the analysis. A total of 3304 documents, mainly articles (n = 2083, 63.0%) and reviews (n = 813, 24.6%), were collected from 1995 to 2022. The average annual growth rate of literature on the topic was 26.7%. Overall 15,176 authors published on the topic, with an average of eight authors/publication. From 1995, 69 countries contributed to the literature, with the USA and Italy being the top contributors. Among all keywords used by authors, the top three were oligometastases (19%), SBRT (18%), and radiation therapy (8%). Themes regarding “locoregional treatment”, “organ motion”, and “immunotherapy” were the most recent trend topics, mainly developed from 2019 to 2022, while “high-dose chemotherapy”, “whole-brain radiotherapy”, and “metastatic breast cancer” saw their main development during 2009–2018. Our study shows the exceptionally flourishing scientific production on the oligometastatic state, summarizing the most influential studies and highlighting the future developments and interests. This analysis will serve as a benchmark to identify this area for the attention of researchers worldwide and contribute to the increasing scientific work.
format Online
Article
Text
id pubmed-10417037
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-104170372023-08-12 A Bibliometric Analysis of the Oligometastatic State over the Last Two Decades: A Shifting Paradigm for Oncology? An AIRO Oligometastatic Study Group Marvaso, Giulia Mastroleo, Federico Corrao, Giulia Zaffaroni, Mattia Vincini, Maria Giulia Borghetti, Paolo Cuccia, Francesco Federico, Manuela Montesi, Giampaolo Pontoriero, Antonio Franceschini, Davide Franzese, Ciro Scorsetti, Marta Jereczek-Fossa, Barbara Alicja Cancers (Basel) Article SIMPLE SUMMARY: The concept of “oligometastatic state” has brought about a shift in our understanding of cancer’s metastasis and progression, and its management remains an active field of research, with ongoing efforts to develop new treatment options. The aim of the present study is to report a bibliometric analysis of the oligometastatic disease/state to provide an overview of the topic. A total of 3304 documents were collected from 1995 to 2022. Among all keywords used by authors, the top three were oligometastases (19%), SBRT (18%), and radiation therapy (8%). In particular, a link can be observed between radiotherapy and topics of side-fields like immunotherapy and targeted therapies, representing an opportunity for further combinatorial studies in this setting. This bibliometric analysis represents a detailed summary of the most influential studies dealing with the oligometastatic state and sheds light on the area for the attention of researchers worldwide. ABSTRACT: The term “oligometastasis” represents a relatively novel idea, which denotes a condition characterized by cancer dissemination with a limited number of lesions (usually fewer than five). The aim of the present study is to report a bibliometric analysis of the oligometastatic disease/state, incorporating all relevant studies on the topic for more than 20 years. The research strategy included at least one the terms “Oligmetastases”, “Oligometastasis”, “Oligometastatic”, “Oligoprogression, “Oligoprogressive”, “Oligorecurrent”, or “Oligorecurrency” in the title, abstract, and/or keywords. All English-language documents from 1 January 1995 (the year of the earliest available document in Scopus) to 31 December 2022 were considered for the analysis. R code (R version 4.2.0) with R Studio (version 2022.12.0-353) and the Bibliometrix package (version 4.0.1) were used for the analysis. A total of 3304 documents, mainly articles (n = 2083, 63.0%) and reviews (n = 813, 24.6%), were collected from 1995 to 2022. The average annual growth rate of literature on the topic was 26.7%. Overall 15,176 authors published on the topic, with an average of eight authors/publication. From 1995, 69 countries contributed to the literature, with the USA and Italy being the top contributors. Among all keywords used by authors, the top three were oligometastases (19%), SBRT (18%), and radiation therapy (8%). Themes regarding “locoregional treatment”, “organ motion”, and “immunotherapy” were the most recent trend topics, mainly developed from 2019 to 2022, while “high-dose chemotherapy”, “whole-brain radiotherapy”, and “metastatic breast cancer” saw their main development during 2009–2018. Our study shows the exceptionally flourishing scientific production on the oligometastatic state, summarizing the most influential studies and highlighting the future developments and interests. This analysis will serve as a benchmark to identify this area for the attention of researchers worldwide and contribute to the increasing scientific work. MDPI 2023-07-31 /pmc/articles/PMC10417037/ /pubmed/37568718 http://dx.doi.org/10.3390/cancers15153902 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Marvaso, Giulia
Mastroleo, Federico
Corrao, Giulia
Zaffaroni, Mattia
Vincini, Maria Giulia
Borghetti, Paolo
Cuccia, Francesco
Federico, Manuela
Montesi, Giampaolo
Pontoriero, Antonio
Franceschini, Davide
Franzese, Ciro
Scorsetti, Marta
Jereczek-Fossa, Barbara Alicja
A Bibliometric Analysis of the Oligometastatic State over the Last Two Decades: A Shifting Paradigm for Oncology? An AIRO Oligometastatic Study Group
title A Bibliometric Analysis of the Oligometastatic State over the Last Two Decades: A Shifting Paradigm for Oncology? An AIRO Oligometastatic Study Group
title_full A Bibliometric Analysis of the Oligometastatic State over the Last Two Decades: A Shifting Paradigm for Oncology? An AIRO Oligometastatic Study Group
title_fullStr A Bibliometric Analysis of the Oligometastatic State over the Last Two Decades: A Shifting Paradigm for Oncology? An AIRO Oligometastatic Study Group
title_full_unstemmed A Bibliometric Analysis of the Oligometastatic State over the Last Two Decades: A Shifting Paradigm for Oncology? An AIRO Oligometastatic Study Group
title_short A Bibliometric Analysis of the Oligometastatic State over the Last Two Decades: A Shifting Paradigm for Oncology? An AIRO Oligometastatic Study Group
title_sort bibliometric analysis of the oligometastatic state over the last two decades: a shifting paradigm for oncology? an airo oligometastatic study group
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417037/
https://www.ncbi.nlm.nih.gov/pubmed/37568718
http://dx.doi.org/10.3390/cancers15153902
work_keys_str_mv AT marvasogiulia abibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup
AT mastroleofederico abibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup
AT corraogiulia abibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup
AT zaffaronimattia abibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup
AT vincinimariagiulia abibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup
AT borghettipaolo abibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup
AT cucciafrancesco abibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup
AT federicomanuela abibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup
AT montesigiampaolo abibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup
AT pontorieroantonio abibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup
AT franceschinidavide abibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup
AT franzeseciro abibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup
AT scorsettimarta abibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup
AT jereczekfossabarbaraalicja abibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup
AT marvasogiulia bibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup
AT mastroleofederico bibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup
AT corraogiulia bibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup
AT zaffaronimattia bibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup
AT vincinimariagiulia bibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup
AT borghettipaolo bibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup
AT cucciafrancesco bibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup
AT federicomanuela bibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup
AT montesigiampaolo bibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup
AT pontorieroantonio bibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup
AT franceschinidavide bibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup
AT franzeseciro bibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup
AT scorsettimarta bibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup
AT jereczekfossabarbaraalicja bibliometricanalysisoftheoligometastaticstateoverthelasttwodecadesashiftingparadigmforoncologyanairooligometastaticstudygroup